Scott D. Grimes - Dec 16, 2021 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role
Director
Signature
/s/ Kirk Somers, Attorney-in-Fact
Stock symbol
CDLX
Transactions as of
Dec 16, 2021
Transactions value $
-$505,180
Form type
4
Date filed
12/20/2021, 04:41 PM
Previous filing
Dec 13, 2021
Next filing
Jan 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDLX Common Stock Will/Inheritance $0 +55.8K $0.00 55.8K Dec 31, 2020 See Footnote F1
transaction CDLX Common Stock Sale -$40.3K -640 -1.16% $63.03* 54.5K Dec 16, 2021 See Footnote F2, F3, F4
transaction CDLX Common Stock Sale -$40.9K -640 -1.17% $63.88* 53.8K Dec 16, 2021 See Footnote F2, F4, F5
transaction CDLX Common Stock Sale -$20.8K -320 -0.59% $65.12* 53.5K Dec 16, 2021 See Footnote F2, F4, F6
transaction CDLX Common Stock Sale -$26.4K -400 -0.75% $66.00* 53.1K Dec 16, 2021 See Footnote F2, F4, F7
transaction CDLX Common Stock Sale -$124K -2K -0.78% $61.96 254K Dec 20, 2021 Direct F8, F9
transaction CDLX Common Stock Sale -$157K -2.5K -0.98% $62.73* 252K Dec 20, 2021 Direct F8, F10
transaction CDLX Common Stock Sale -$83K -1.3K -0.52% $63.88* 250K Dec 20, 2021 Direct F8, F11
transaction CDLX Common Stock Sale -$12.9K -200 -0.08% $64.66* 250K Dec 20, 2021 Direct F8, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reportable securities are held by the UTMA Custodial account fbo Pierce Grimes.
F2 These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustee of the 2013 Scott Grimes GRAT UAD (the "GRAT") on November 15, 2019, as amended March 12, 2020.
F3 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $62.45 to $63.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (5), (6), (7), (9), (10), (11) and (12) to this Form 4.
F4 The reportable securities are held by the GRAT.
F5 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $63.45 to $64.43, inclusive.
F6 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $64.56 to $65.55, inclusive.
F7 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $65.62 to $66.60, inclusive.
F8 These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2020, as amended June 15, 2021.
F9 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $61.34 to $62.30, inclusive.
F10 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $62.34 to $63.27, inclusive.
F11 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $63.60 to $64.50, inclusive.
F12 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $64.61 to $64.70, inclusive.